In the 15 minutes a primary care doctor typically has with a patient, she’s expected to diagnose the current ailment, help manage ongoing health issues and provide preventive care. In this setting,…
Category: News
Sirius receives U.S. patent for SNP in Protein C gene
Sirius Genomics, a developer of companion diagnostics, announced today that U.S. Patent # 7,820,376 entitled “Protein C Polymorphisms” has been issued by the United States Patent and Trademark Office. The patent relates…
States, insurers, employers move forward with health law implementation
News outlets report on efforts to implement the new health law, including high risk pools and insurers’ summaries of their plans. High risk pools, which began accepting applications over the summer, are…
Researchers find role of long-non-protein coding RNAs in viral infection
Long, non-protein-coding RNAs may help regulate innate immunity For the first time, scientists have discovered that a poorly understood class of RNA produced in a mammal’s cells during a respiratory virus attack…
Illumina announces single flow cell version of HiSeq 2000 sequencing system
Illumina, Inc. (NASDAQ:ILMN) today announced HiSeq 1000, a single flow cell version of the company’s HiSeq 2000 sequencing system. HiSeq 1000 is designed for researchers who want the ease of use, industry-leading…
Trilogy receives four-year federal grant from SAMHSA
Trilogy, Inc., a behavioral healthcare organization serving people in recovery from serious mental illness, is the recipient of a four-year federal grant from the national Substance Abuse and Mental Health Services Administration…
Medicare growing fiscally unsustainable yet remains politically untouchable
Medicare, “an indispensable safety net,” is fiscally unsustainable in the long term, yet it may be politically untouchable, The Center for Public Integrity reports in the first of a multipart series. “With…
Study finds anti-obesity drug reduces brain’s response to appetizing foods
Study on effects of anti-obesity drug on the brain paves way for more effective treatments Scientists have revealed that an anti-obesity drug changes the way the brain responds to appetising, high-calorie foods…
Boehringer Ingelheim and MacroGenics enter global antibody-based therapeutics alliance
Boehringer Ingelheim and MacroGenics today jointly announced that they have entered into a global alliance to discover, develop and commercialize antibody-based therapeutics which may span multiple therapeutic areas, including immunology, oncology, respiratory,…
Jamieson releases flu-fighting formula with echinacea
FluShield™ provides major breakthrough in immune-boosting natural medicines Jamieson Laboratories, Canada’s largest manufacturer of advanced natural-health products, announced the release of FluShield™, a clinically proven flu-fighting formula that is made with a…
Study finds association between KRAS p.G13D mutations and cetuximab treatment in colorectal cancer
Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a…
Rush University awards $25 million contract to Siemens
Rush University Medical Center in Chicago, one of the top academic medical centers in the United States, has awarded a five-year, $25 million contract for medical equipment and health IT consulting services…
Adherence to lifestyle recommendations reduce risk of colorectal cancer by 23%
Association of adherence to lifestyle recommendations and risk of colorectal cancer: A prospective Danish cohort study Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle…
Golden Helix accelerates copy number variation detection methodology
Golden Helix, Inc., today announced the incorporation of technologies that will greatly accelerate genetic research. By enabling the company’s SNP & Variation Suite software to run on off-the-shelf video graphics cards, or…
MacroGenics, Pfizer enter global research collaboration and license agreement for DART products
MacroGenics, Inc., a leader in next-generation antibody platforms and therapeutics, announced today that it has entered into a global research collaboration and license agreement with Pfizer Inc. to discover, develop and commercialize…